Anton von Rueden - 31 May 2022 Form 4 Insider Report for Aterian, Inc. (ATER)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 May 2022, 21:05:12 UTC
Prior SEC filing
22 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anton von Rueden

Key filing fact

Anton von Rueden filed Form 4 for Aterian, Inc. (ATER) on 31 May 2022.

Key facts

  • This page summarizes Anton von Rueden's Form 4 filing for Aterian, Inc. (ATER).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 May 2022, 21:05.

Change

  • Previous filing in this sequence was filed on 22 Apr 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATER transaction

Common Stock

Award

Transaction value
$0
Shares
+500,000
Change %
Price
$0.000000
Shares after
500,000
Date
31 May 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Comprised of 500,000 shares of restricted common stock granted pursuant to the Issuer's 2022 Inducement Equity Incentive Plan that are subject to vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .